BA.2 Covid Variant Is Already Changing the U.S. Response to the Pandemic - Barron's

The BA.2 variant isn't yet dominant in the U.S., but theFDA has limited the use of a Covid-19 monoclonal antibody therapy thought to be ineffective against it.

The BA.2 variant isnt yet dominant in the U.S., but its already forcing substantial shifts in the countrys approach to controlling the pandemic. On Friday, the Food and Drug Administration limited t… [+249 chars]

full article...